The medications will now cost between $149 and $350 a month under the deal, depending on insurance coverage or whether patients pay out of pocket. The price drop will apply to Medicare Managing patients taking glucagon like peptide 1 receptor agonists: proceed with caution British Journal of Anaesthesia Newest FDA approved weight loss medication!, Once weekly dual receptor incretin agonist tirzepatide gains FDA approval for use in obesity therapy (no need for underlying type 2 diabetes)., It's always Phentermine Alternatives: 6 Weight Loss Medications to Consider GoodRx